CRP and Stroke: Unlike traditional clinical scales such as NIHSS, which mainly assess neurological severity, or inflammatory biomarkers like CRP, the WBC/HDL ratio integrates both inflammatory and lipid metabolic pathways, offering complementary information that can enhance stroke prognosis prediction.